Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,071 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $206.25 | 2 | $0 (2017) |
| Gilead Sciences, Inc. | $198.00 | 2 | $0 (2019) |
| Allergan Inc. | $180.28 | 2 | $0 (2018) |
| Celgene Corporation | $137.89 | 1 | $0 (2017) |
| Amgen Inc. | $99.00 | 1 | $0 (2018) |
| PFIZER INC. | $99.00 | 1 | $0 (2019) |
| Medtronic Vascular, Inc. | $56.30 | 1 | $0 (2019) |
| Egalet US Inc | $40.80 | 1 | $0 (2017) |
| Pernix Therapeutics Holdings, Inc. | $34.93 | 1 | $0 (2017) |
| Exact Sciences Corporation | $18.24 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.24 | 1 | Exact Sciences Corporation ($18.24) |
| 2019 | $254.30 | 3 | Gilead Sciences, Inc. ($99.00) |
| 2018 | $282.77 | 3 | Amgen Inc. ($99.00) |
| 2017 | $515.38 | 6 | Janssen Pharmaceuticals, Inc ($206.25) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Oncology | ||||||
| 11/12/2019 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $56.30 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 09/10/2019 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: HCV | ||||||
| 05/14/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2018 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: Endocrinology | ||||||
| 05/08/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $84.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/13/2018 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $99.00 | General |
| Category: HCV | ||||||
| 07/27/2017 | Celgene Corporation | GED-0301 (Drug) | Food and Beverage | In-kind items and services | $137.89 | General |
| 07/11/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $119.36 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $86.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/10/2017 | Allergan Inc. | BYVALSON (Drug), BYSTOLIC | Food and Beverage | In-kind items and services | $95.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/25/2017 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $40.80 | General |
| Category: Pain Medicine | ||||||
| 02/25/2017 | Pernix Therapeutics Holdings, Inc. | ZOHYDRO ER (Drug) | Food and Beverage | In-kind items and services | $34.93 | General |
| Category: PAIN | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 967 | 1,069 | $468,635 | $114,865 |
| 2022 | 11 | 921 | 1,024 | $443,545 | $110,599 |
| 2021 | 10 | 950 | 1,086 | $457,710 | $118,471 |
| 2020 | 11 | 1,018 | 1,194 | $465,470 | $108,621 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 169 | 169 | $55,770 | $20,984 | 37.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 202 | 237 | $130,350 | $19,251 | 14.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 184 | 244 | $35,380 | $16,627 | 47.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 97 | 98 | $83,300 | $14,243 | 17.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 129 | 135 | $28,350 | $13,061 | 46.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 42 | 42 | $17,010 | $6,971 | 41.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 48 | 48 | $38,400 | $6,701 | 17.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 35 | 35 | $28,000 | $6,216 | 22.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 26 | 26 | $20,800 | $4,766 | 22.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 20 | 20 | $27,000 | $3,948 | 14.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 15 | 15 | $4,275 | $2,097 | 49.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 223 | 260 | $143,000 | $23,155 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 143 | 143 | $47,190 | $18,620 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 193 | 253 | $36,685 | $17,249 | 47.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 101 | 102 | $86,700 | $15,177 | 17.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 115 | $24,150 | $11,446 | 47.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 47 | 47 | $37,600 | $6,795 | 18.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 33 | 33 | $13,365 | $5,740 | 42.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 18 | 18 | $24,300 | $3,708 | 15.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 23 | $6,555 | $3,295 | 50.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 17 | 17 | $13,600 | $2,988 | 22.0% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $10,400 | $2,427 | 23.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 208 | 259 | $142,450 | $23,577 | 16.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 212 | 286 | $41,470 | $20,324 | 49.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 139 | 139 | $45,870 | $18,607 | 40.6% |
About Dr. Ronald Roth, MD
Dr. Ronald Roth, MD is a Gastroenterology healthcare provider based in Tavares, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013105253.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ronald Roth, MD has received a total of $1,071 in payments from pharmaceutical and medical device companies, with $18.24 received in 2024. These payments were reported across 13 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,071).
As a Medicare-enrolled provider, Roth has provided services to 3,856 Medicare beneficiaries, totaling 4,373 services with total Medicare billing of $452,556. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Tavares, FL
- Active Since 10/12/2007
- Last Updated 10/12/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1013105253
Products in Payments
- Epclusa (Drug) $198.00
- GED-0301 (Drug) $137.89
- XARELTO (Drug) $119.36
- ELIQUIS (Drug) $99.00
- Prolia (Biological) $99.00
- BYVALSON (Drug) $95.51
- INVOKANA (Drug) $86.89
- AVYCAZ (Drug) $84.77
- Reveal LINQ (Device) $56.30
- SPRIX (Drug) $40.80
- ZOHYDRO ER (Drug) $34.93
- Cologuard Collection Kit (Device) $18.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Tavares
Soundarapandian Baskar, Md, MD
Gastroenterology — Payments: $5,398
Christina Covelli, M.d, M.D
Gastroenterology — Payments: $3,244
Bharathi Ramaiah, Md, MD
Gastroenterology — Payments: $3,168
Dr. Kegan Jessamy, Mbbs, MBBS
Gastroenterology — Payments: $1,171
Dr. Jeffrey Goodman, Md, MD
Gastroenterology — Payments: $123.37